Aliases & Classifications for Proctitis

About this section

Aliases & Descriptions for Proctitis:

Name: Proctitis 10 47 12 36 65
 
Proctitis Nos 10

Classifications:



External Ids:

Disease Ontology10 DOID:3127
ICD1027 K62.89
MeSH36 D011349
NCIt42 C38011
UMLS65 C0033246

Summaries for Proctitis

About this section
Disease Ontology:10 A rectal disease that involves inflammation of the rectal mucosa, which results from infection, inflammatory bowel disease, or radiation. Sexually transmitted pathogens (Neisseria gonorrhoeae, Chlamydia trachomatis, herpes simplex virus 1 and 2, Treponema pallidum) and enteric pathogens (Campylobacter, Shigella, Salmonella) are involved in the disease. Symptoms are rectal discomfort and bleeding.

MalaCards based summary: Proctitis, also known as proctitis nos, is related to lymphocytic colitis and radiation proctitis, and has symptoms including rectal inflammations nec An important gene associated with Proctitis is EPX (Eosinophil Peroxidase), and among its related pathways are G-protein signaling_K-RAS regulation pathway and LDL Oxidation in Atherogenesis. The drug mesalamine has been mentioned in the context of this disorder. Affiliated tissues include prostate, breast and thyroid, and related mouse phenotypes are muscle and hematopoietic system.

Wikipedia:68 Proctitis is an inflammation of the anus and the lining of the rectum, affecting only the last 6 inches... more...

Related Diseases for Proctitis

About this section

Diseases related to Proctitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 152)
idRelated DiseaseScoreTop Affiliating Genes
1lymphocytic colitis29.9LTF, MPO, RNASE3
2radiation proctitis12.4
3ulcerative proctitis12.4
4winchester syndrome10.7EPX, RNASE3
5mixed extragonadal germ cell cancer10.6EPX, RNASE3
6listeriosis10.6LTF, TNF
7rhizomelic dysplasia patterson lowry type10.6LTF, TNF
8eosinophilic cryptitis10.6EPX, MPO
9benign paroxysmal positional nystagmus10.6EPX, RNASE3
10anterior dislocation of lens10.6LTF, RNASE3
11microsomia hemifacial radial defects10.6MPO, TNF
12papillary conjunctivitis10.6LTF, RNASE3
13vulva fibroepithelial polyp10.6EPX, MPO
14androgen insensitivity syndrome, mild10.6MPO, TNF
15hypergonadotropic ovarian failure, familial or sporadic10.6EPX, RNASE3
16chronic conjunctivitis10.6EPX, LTF
17rubeosis iridis10.6LTF, TNF
18skin conditions10.6RNASE3, TNF
19peripheral retinal degeneration10.6LTF, TNF
20goat milk allergy10.5RNASE3, TNF
21post-traumatic stress disorder10.5MPO, RNASE3
22lujo hemorrhagic fever10.5CRP, TNF
23rhinoscleroma10.5CRP, TNF
24hepatoid adenocarcinoma10.5RNASE3, TNF
25familial hyperlipidemia10.5EPX, RNASE3
26ischemic optic neuropathy10.5CRP, TNF
27turner syndrome10.5CRP, TNF
28disseminated eosinophilic collagen disease10.5EPX, RNASE3
29colitis10.5
30ileocolitis10.5MPO, TNF
31rhabdoid cancer10.5CRP, LTF
32simple chronic conjunctivitis10.5CRP, LTF
33spondylocamptodactyly10.5CRP, TNF
34qualitative platelet defect10.5MPO, RNASE3
35ureteral disease10.5CRP, TNF
36cervical wilms' tumor10.5CRP, MPO
37calpainopathy10.5CRP, MPO
38diabetic ketoacidosis10.5CRP, MPO
39neuritis10.5CRP, MPO
40submandibular gland disease10.5LTF, TNF
41papillary pattern testicular yolk sac tumor10.5CRP, MPO
42periodontal disease10.4LTF, TNF
43ulcerative colitis10.4
44cryptogenic organizing pneumonia10.4CRP, MPO
45dentin caries10.4CRP, TNF
46exudative glomerulonephritis10.4CRP, MPO
47diffuse secondary choroid atrophy10.4CRP, MPO
48chronic sphenoidal sinusitis10.4MPO, RNASE3
49oral squamous cell carcinoma10.4CRP, MPO
50focal labyrinthitis10.4CRP, MPO

Graphical network of the top 20 diseases related to Proctitis:



Diseases related to proctitis

Symptoms for Proctitis

About this section

UMLS symptoms related to Proctitis:


rectal inflammations nec

Drugs & Therapeutics for Proctitis

About this section

Drugs for Proctitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 37)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SucralfateapprovedPhase 4954182-58-0
Synonyms:
Carafate
Hexadeca-μ-hydroxytetracosahydroxy[μ8-[1,3,4,6-tetra-O-sulfo-β-Dfructofuranosyl-α-D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum
Sucralfat
 
Sucralfate
Sucralfato
Sucralfatum
Sulcrate
2
Tacrolimusapproved, investigationalPhase 4, Phase 21023104987-11-3445643, 439492, 445647
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
8-DEETHYL-8-[but-3-enyl]-ascomycin
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
FR900506
 
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
Hecoria
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus Hydrate
Tacrolimus anhydrous
Tacrolimus hydrate
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
3Gastrointestinal AgentsPhase 4, Phase 26401
4Anti-Ulcer AgentsPhase 41453
5AntacidsPhase 41453
6Immunosuppressive AgentsPhase 4, Phase 210422
7Immunologic FactorsPhase 4, Phase 218483
8Calcineurin InhibitorsPhase 41223
9
BudesonideapprovedPhase 3, Phase 238151333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide Inhalation
Budesonide MMX
Budesonide Nasal
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
 
Horacort
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort FLEXHALER
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Uceris
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
10
Inulinapproved, nutraceuticalPhase 3959005-80-524763
Synonyms:
(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethy
189444-25-5
887747-94-6
AC1L2NNM
AI3-19506
CID24763
DB00638
 
EINECS 232-684-3
INULIN
Inulin USP 27
Inulin [BAN]
Inulin and sodium chloride
Inulin from Jerusalem artichokes
LS-186416
LS-187349
11AnalgesicsPhase 3, Phase 29358
12MesalaminePhase 3, Phase 215289-57-6
13Antirheumatic AgentsPhase 3, Phase 28496
14Peripheral Nervous System AgentsPhase 3, Phase 218510
15Anti-Inflammatory Agents, Non-SteroidalPhase 3, Phase 23549
16Analgesics, Non-NarcoticPhase 3, Phase 25184
17Respiratory System AgentsPhase 3, Phase 23931
18Anti-Asthmatic AgentsPhase 3, Phase 22796
19Bronchodilator AgentsPhase 3, Phase 22377
20glucocorticoidsPhase 3, Phase 23896
21Hormone AntagonistsPhase 3, Phase 210002
22HormonesPhase 3, Phase 211748
23Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 29988
24Anti-Inflammatory AgentsPhase 3, Phase 28478
25ColaNutraceuticalPhase 3, Phase 21768
26AcidophilusNutraceuticalPhase 2, Phase 3482
27
Propofolapproved, investigationalPhase 29312078-54-84943
Synonyms:
2, 6-Diisopropylphenol
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Bis(Isopropyl)-phenol
2,6-DIISOPROPYLPHENOL
2,6-Diisopropyl phenol
2,6-Diisopropylphenol
2,6-bis(1-methylethyl)-phenol
2,6-di(propan-2-yl)phenol
2078-54-8
28449-97-0
4-06-00-03435 (Beilstein Handbook Reference)
50356-15-5
AB00513968
AC-2038
AC1L1J9Y
AC1Q1OUI
AI3-26295
AM-149
Abbott Brand of Propofol
Alpha Brand of Propofol
Ampofol
Aquafol
Astra Brand of Propofol
AstraZeneca Brand of Propofol
BIDD:GT0436
BPBio1_000950
BPBio1_000969
BRD-K82255054-001-03-5
BRN 1866484
BSPBio_000862
Biomol-NT_000248
Braun Brand of Propofol
C07523
C12H18O
CAS-2078-54-8
CCRIS 9000
CHEBI:44915
CHEMBL526
CID4943
CPD-11437
CPD000059151
Curamed Brand of Propofol
D00549
D015742
D0617
D126608
D126608_ALDRICH
DB00818
DDS-04F
Diisopropylphenol
Dipravan
Diprivan
Diprivan (TN)
Diprivan Injectable emulsion
Disoprivan
Disoprofol
EINECS 218-206-6
EU-0100437
Fresenius Brand of Propofol
Fresenius Kabi Brand of Propofol
Fresofol
HMS1570L04
HMS2089O21
HMS2094E17
 
HSDB 7123
ICI 35,868
ICI 35868
ICI-35,868
ICI-35868
ICI35,868
ICI35868
InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H
Ivofol
Jsp004266
Juste Brand of Propofol
LS-996
Lopac-D126608
Lopac0_000437
MLS001066348
MLS001335999
MLS002454360
MolPort-001-794-517
NCGC00015389-01
NCGC00015389-02
NCGC00015389-04
NCGC00015389-09
NCGC00091538-01
NCGC00091538-02
NCGC00091538-03
NCGC00091538-04
NCGC00091538-05
NCGC00091538-06
NSC 5105
NSC5105
PFL
Parnell Brand of Propofol
Pisa Brand of Propofol
Prestwick0_000931
Prestwick1_000931
Prestwick2_000931
Prestwick3_000931
Propofol
Propofol (JAN/USAN/INN)
Propofol Abbott
Propofol Fresenius
Propofol IDD-D
Propofol MCT
Propofol Rovi
Propofol [USAN:INN:BAN]
Propofol(2,6-Diisopropylphenol)
Propofol-Lipuro
Propofolum
Propofolum [Latin]
Rapinovet
Recofol
Rovi Brand of Propofol
S01-0189
SAM002264610
SMR000059151
SPBio_003031
SPECTRUM1505022
ST50405911
Schering Brand of Propofol
UNII-YI7VU623SF
W505102_ALDRICH
ZD-0859
ZINC00968303
Zeneca Brand of Propofol
ghl.PD_Mitscher_leg0.558
nchembio.552-comp7
propofol
28
Midazolamapproved, illicitPhase 263559467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
Dormicum
 
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam Hydrochloride
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
29
BisacodylapprovedPhase 267603-50-9
Synonyms:
Best Choice Bisacodyl Laxative
Bisac-evac
Bisacodilo
Bisacody Enteric Coated
Bisacodyl
Bisacodyl Enteric Coated
Bisacodyl Laxative
Bisacodyl Laxative Enteric Coated
Bisacodyl Stimulant Laxative
Bisacodyl stimulant laxative
Bisacodyle
Bisacodylum
Biscolax
Biscolax Laxative
C Lax Laxative
C-lax Laxative
Carters Little Pills Sodium-Free
Crh Medsense Bisacodyl Stimulant Laxative
Dulcolax
Dulcolax Pink
Enteric Coated Stimulant Laxative
Equaline Laxative
Ez2go
Ez2go Stimu-lax
Fleet
Gentle Laxative
 
Gentle Laxative Enteric Coated
Gentle Laxative For Women stimulant laxative
Gentle Laxative Stimulant Laxative
Health Sense Ducodyl
Laxative
Laxative Enteric Coated
Laxative For Women
Laxative Gentle
Laxative Womens
Leader Gentle Laxative
Leader Womens Laxative
Medique Medi-lax
New Correct
P Lax Dr
Phenol, 4,4'-(2-pyridinylmethylene)bis-, diacetate (ester)
Simpex Bisacodyl Laxative
Spirolax
Stimulant Laxative
Stimulant Laxative Enteric Coated
Stratuscare Bisacodyl
Sunmark Womans Laxative
The Medicine Shoppe Gentle Laxative
Topcare Laxative
Unit Dose Bisacodyl
Womans Laxative
Womens Gentle Laxative
Womens Laxative
Y Lax Dr
30
Fentanylapproved, illicit, investigationalPhase 2705437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Abstral
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl - Novaplus
Fentanyl Citrate
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
 
Fentanyl-12
Fentanyl-25
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Lazanda
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
Subsys
UNII-UF599785JZ
fentanyl
31
CisplatinapprovedPhase 2254015663-27-184093, 441203, 2767
Synonyms:
(SP-4-1)-diamminedichloridoplatinum
(SP-4-1)-diamminedichloroplatinum
(SP-4-2)-diamminedichloridoplatinum
(SP-4-2)-diamminedichloroplatinum
Abiplatin
Biocisplatinum
Briplatin
CACP
CDDP
CHEBI:35852
CID441203
CPD0-1392
CPDC
CPDD
Carboquone
Cis Pt II
Cis-DDP
Cis-Diaminedichloroplatinum
Cis-Diamminedichloroplatinum
Cismaplat
Cisplatin
Cisplatine
Cisplatino
Cisplatinum
Cisplatyl
Citoplationo
DB00515
DDP
DDPT
Diamminedichloroplatinum
 
EU-0100918
Lederplatin
Neoplatin
Peyrone's chloride
Peyrone's salt
Plastin
Platamine
Platiblastin
Platidiam
Platinex
Platinol
Platinol-AQ
Platinol-aq
Platinoxan
Platinum Ammine Chloride
Platinum Ammonium Chloride
Platinum Diamine Dichloride
Randa
Trans-DDP
Trans-Diaminedichloroplatinum
Trans-Diamminedichloroplatinum
Trans-Dichlorodiammine Platinum
Trans-Platinumdiammine Dichloride
cis-DDP
cis-Diamminedichloroplatinum
cis-Dichlorodiammineplatinum(II)
cis-[PtCl2(NH3)2]
cis-diamminedichloridoplatinum(II)
cis-diamminedichloroplatinum(II)
nchembio773-comp1
trans-diamminedichloridoplatinum(II)
32
HyaluronanapprovedPhase 23629067-32-7, 9004-61-953477741, 24759
Synonyms:
Hyaluronate
Hyaluronic acid
Hyaluronic acid sodium salt
Hylartil
Hyruan Plus
Luronit
Macronan
 
Mucoitin
Nutra-HAF
Q 5AQ
Sepracoat
Sepragel Sinus
Sodium hyaluronate
Sofast
Synvisc
33
CurcuminPhase 2124458-37-7969516
Synonyms:
1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione
C.I. Natural Yellow 3
CI Natural Yellow 3
Cucurmin
Curcuma
Curcumin
Curcumin I
Diferaloylmethane
Diferuloylmethane
Gelbwurz
Golden seal
Haidr
Halad
Haldar
Halud
Hydrastis
 
Indian saffron
Indian turmeric
Kacha haldi
Kurkumin [czech]
Merita earth
Natural yellow 3
Orange root
Safran D'inde
Souchet
Terra merita
Tumeric yellow
Turmeric
Turmeric (>98% curcurmin)
Turmeric oleoresin (79%-85% curcumin)
Turmeric yellow
Yellow ginger
Yellow puccoon
Yellow root
Yo-kin
Zlut prirodni 3 [Czech]
34OrangeNutraceuticalPhase 2217
35
Epinephrineapproved83451-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenaclick
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
Auvi-q
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine bitartrate
Epinephrine chloride
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr
Epipen Jr.
Epipen Jr. Auto-Injector
Epipen jr
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
 
Esphygmogenina
Exadrin
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
Primatene Mist Refill
Prime Asthma Relief
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
36Racepinephrine834
37Epinephryl borate834

Interventional clinical trials:

(show all 30)
idNameStatusNCT IDPhase
1Combined Therapy in Radiation ProctopathyCompletedNCT01613534Phase 4
2Rectal Tacrolimus in the Treatment of Resistant Ulcerative ProctitisRecruitingNCT01418131Phase 4
3CryoSpray Ablation(TM)to Determine Safety and Feasibility in Radiation Induced ProctitisWithdrawnNCT00756197Phase 4
4The Safety and Tolerability of Budesonide Foam in Subjects With Active Ulcerative Proctitis or ProctosigmoiditisCompletedNCT01349673Phase 3
5Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis SymptomsCompletedNCT01901042Phase 2, Phase 3
6Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or ProctosigmoiditisCompletedNCT01008423Phase 3
7Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or ProctosigmoiditisCompletedNCT01008410Phase 3
8Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet.RecruitingNCT01414517Phase 3
9Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative ProctitisTerminatedNCT01016262Phase 3
10Clinical Trial With Mesalamine 1g SuppositoriesTerminatedNCT01172444Phase 3
11Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue InjuriesTerminatedNCT00134628Phase 3
12Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative ProctitisCompletedNCT01837615Phase 2
13Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative ProctitisCompletedNCT01966783Phase 2
14Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.CompletedNCT02104271Phase 2
15Ion Prostate IrradiationCompletedNCT01641185Phase 2
16Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)RecruitingNCT02724618Phase 2
17Brachytherapy for Recurrent Prostate CancerActive, not recruitingNCT01956058Phase 2
18Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By SurgeryActive, not recruitingNCT00331760Phase 2
19Budesonide Foam Versus Placebo for Prevention of Acute Radiation ProctitisTerminatedNCT00828230Phase 2
20Medical Treatment of Colitis in Patients With Hermansky-Pudlak SyndromeWithdrawnNCT00514982Phase 2
21Treatment of Hemorrhagic Radiation Proctitis Using the Halo SystemCompletedNCT01103492
22Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis DiseaseCompletedNCT02025777
23Patients Overexposed for a Prostate AdenocarcinomaCompletedNCT00773656
24Confocal Laser Endomicroscopy Findings in Patients With Proctosigmoiditis Before and After Initiation of TreatmentCompletedNCT01684514
25Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder CancerCompletedNCT01142102
26QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)RecruitingNCT02368743
27Faecal Incontinence iNtervention StudyRecruitingNCT02355834
28Invasive Group A Streptococcus (GAS) Infection in Children: Bacterial Virulence Factors and Detection of Host Immunological and/or Genetic Factors of Predisposition to InfectionsRecruitingNCT02010294
29Phenomics in Autoimmune and Inflammatory DiseasesRecruitingNCT02466217
30Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation ProctitisNot yet recruitingNCT02233933

Search NIH Clinical Center for Proctitis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: proctitis

Genetic Tests for Proctitis

About this section

Anatomical Context for Proctitis

About this section

MalaCards organs/tissues related to Proctitis:

33
Prostate, Breast, Thyroid, Colon, Endothelial, Skin, Bone

Animal Models for Proctitis or affiliated genes

About this section

MGI Mouse Phenotypes related to Proctitis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053697.6ENTPD1, FGF2, MPO, PECAM1, TNF
2MP:00053977.0ENTPD1, EPX, FGF2, LTF, MPO, PECAM1
3MP:00053876.7CRP, ENTPD1, EPX, LTF, MPO, PECAM1

Publications for Proctitis

About this section

Articles related to Proctitis:

(show top 50)    (show all 570)
idTitleAuthorsYear
1
Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression. (26663677)
2016
2
The Efficacy of Probiotic (Lactobacillus rhamnosus GG) and 5-ASA (Aminosalicylic Acid) in the Treatment of Experimental Radiation Proctitis in Rats. (26730065)
2015
3
Comparison of Xilei-san, a Chinese herbal medicine, and dexamethasone in mild/moderate ulcerative proctitis: a double-blind randomized clinical trial. (23383973)
2013
4
Can we decrease the acute proctitis in prostate cancer patients using hyaluronic acid during radiation therapy: a prospective historically controlled clinical study. (23690202)
2013
5
Protective role of antiplatelet treatment against ulcer formation due to argon plasma coagulation in patients treated for chronic radiation proctitis. (24138319)
2013
6
Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man. (22465339)
2012
7
Can we decrease the acute proctitis in prostate cancer patients using hyaluronic acid during radiation therapy: a prospective historically controlled clinical study. (22774405)
2012
8
Large-volume argon plasma coagulation in the management of chronic radiation proctitis. (21353865)
2011
9
Case of secondary syphilis presenting with unusual complications: syphilitic proctitis, gastritis, and hepatitis. (21998411)
2011
10
The effect of a flavonoid fractions diosmin + hesperidin on radiation-induced acute proctitis in a rat model. (21768702)
2011
11
Systemic lupus erythematosus presenting as ischaemic proctitis. (21300684)
2011
12
Cytomegalovirus proctitis: a rare and disregarded sexually transmitted disease. (21844745)
2011
13
A murine model for the study of molecular pathogenesis of radiation proctitis. (20005457)
2010
14
Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents. (20848454)
2010
15
Images in clinical medicine. Radiation proctitis. (20843251)
2010
16
Topically administered infliximab can work in ulcerative proctitis despite the ineffectiveness of intravenous induction therapy. (19436284)
2009
17
Pica-induced proctitis? (19506441)
2009
18
Diagnosing chlamydia and managing proctitis in men who have sex with men: current UK practice. (18077609)
2008
19
Images in HIV/AIDS. HIV-associated lymphogranuloma venereum proctitis. (17396331)
2007
20
Increase of hepcidin plasma and urine levels is associated with acute proctitis and changes in hemoglobin levels in primary radiotherapy for prostate cancer. (17393200)
2007
21
Application of 10 percent formalin for the treatment of radiation-induced hemorrhagic proctitis. (17080283)
2007
22
Histopathological comparison of topical therapy modalities for acute radiation proctitis in an experimental rat model. (16937473)
2006
23
Formalin application in the treatment of chronic radiation-induced hemorrhagic proctitis induces acute deterioration of mucosal blood flow. (16416079)
2006
24
Sucralfate does not ameliorate acute radiation proctitis: randomised study and meta-analysis. (16149294)
2005
25
Formalin dab for radiation proctitis--an effective day care procedure. (16114161)
2005
26
Formalin application in the treatment of chronic radiation-induced hemorrhagic proctitis--an effective but not risk-free procedure: a prospective study of 33 patients. (15933799)
2005
27
Efficacy and safety of argon plasma coagulation for the treatment of hemorrhagic radiation proctitis. (15584849)
2004
28
Ulcerative proctitis. (20011281)
2004
29
Formaldehyde application for haemorrhagic radiation-induced proctitis: a clinical and histological study. (12780922)
2003
30
Ulcerating proctitis in a patient with congenital neutropenia. (12809854)
2003
31
Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. (12126250)
2002
32
Diverting loop colostomy for the treatment of refractory gastrointestinal bleeding secondary to radiation proctitis. (11778411)
2001
33
A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. (10811338)
2000
34
The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). (10685752)
2000
35
Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. (11072170)
2000
36
Cytomegalovirus proctitis in a diabetic. (9933671)
1999
37
Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized, double-blind, controlled trial. (10378604)
1999
38
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis. (9510317)
1998
39
The ileocecal reservoir for rectal replacement in complicated radiation proctitis. (8873525)
1996
40
Pharmacokinetics of budesonide enema in patients with distal ulcerative colitis or proctitis. (8218754)
1993
41
Aminophylline suppository-induced acute proctitis. (1615945)
1992
42
Proctitis cystica profunda in paraplegics. Report of three cases. (1473421)
1992
43
Preliminary results of a phase I/II study of sodium pentosanpolysulfate in the treatment of chronic radiation-induced proctitis. (1689537)
1990
44
Nonspecific ulcerative proctitis. (3298052)
1987
45
Ischaemic proctitis and adventitial fibromuscular dysplasia of the superior rectal artery. (6689966)
1984
46
Proctitis. (6853994)
1983
47
Confirmatory serodiagnosis of lymphogranuloma venereum proctitis may yield false-positive results due to other chlamydial infections of the rectum. (7221807)
1981
48
Campylobacter proctitis in a homosexual man. (7436170)
1980
49
Traumatic proctitis. (7394693)
1980
50
Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. (6107263)
1980

Variations for Proctitis

About this section

Expression for genes affiliated with Proctitis

About this section
Search GEO for disease gene expression data for Proctitis.

Pathways for genes affiliated with Proctitis

About this section

GO Terms for genes affiliated with Proctitis

About this section

Biological processes related to Proctitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1hydrogen peroxide catabolic processGO:004274410.0EPX, MPO
2negative regulation of growth of symbiont in hostGO:00441309.8MPO, TNF
3negative regulation of viral genome replicationGO:00450719.7LTF, TNF
4positive regulation of MAP kinase activityGO:00434069.4FGF2, TNF
5defense response to Gram-positive bacteriumGO:00508309.3CRP, RNASE3, TNF

Sources for Proctitis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet